|
HS Code |
762356 |
| Productname | 8-Bromoquinazolin-(2,4)Dione |
| Casnumber | 7418-26-4 |
| Molecularformula | C8H5BrN2O2 |
| Molecularweight | 241.04 g/mol |
| Appearance | Off-white to yellow solid |
| Meltingpoint | 292-294 °C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Purity | Typically ≥ 98% |
| Storagetemperature | Store at room temperature |
| Iupacname | 8-Bromoquinazoline-2,4(1H,3H)-dione |
| Smiles | Brc1cccc2c(=O)ncnc2c1 |
| Inchi | InChI=1S/C8H5BrN2O2/c9-4-1-2-5-6(3-4)7(12)10-8(13)11-5/h1-3H,(H2,10,11,12,13) |
As an accredited 8-Bromoquinazolin-(2,4)Dione factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 8-Bromoquinazolin-(2,4)Dione prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Researchers spend a lot of time looking for next-step molecules to push boundaries in life sciences and materials development. 8-Bromoquinazolin-(2,4)Dione is one such compound that’s started to catch the eye of scientists who need a stable, adaptable building block for their experiments or product pipelines. From the first blush, this molecule offers a balance of reliability and creative potential, especially in medicinal chemistry and organic synthesis. Folks in research labs and chemical manufacturing alike are starting to treat this compound less like a specialty material and more like a staple for inventive projects.
The name 8-Bromoquinazolin-(2,4)Dione carries the story right in its structure: It presents a modified quinazoline core, and the bromine atom at the eighth position changes how it interacts during synthesis and downstream chemistry. Unlike standard quinazolinones, this particular modification simplifies some of the tricky steps scientists face when designing new pharmaceutical candidates or advanced polymers. Labs focused on drug discovery and those engineering new fluorophores often rely on such tweaks to produce sharper results, quicker and with steadier yields.
Quality matters in the lab, and this is where 8-Bromoquinazolin-(2,4)Dione starts to earn respect. Purity usually surpasses 98%, removing noise so results stay trustworthy. Chemists working day-to-day know that a clean, dependable reagent saves time and frustration. In my own experience running synthetic reactions, even a small percentage of unwanted byproducts introduce headaches downstream—troubleshooting chromatography purifications, repeating washed-out NMR readings, or sorting through ambiguous bioassay results. A batch of this quinazolinone that stays consistent across shipments gives a welcome sense of confidence, and it translates directly into more predictable results for anyone relying on it in a multi-step process.
Colleagues gravitate to this compound for multiple reasons. In drug design, that bromine atom opens doors for further modification—the so-called “handle” for Suzuki or Buchwald-Hartwig cross-coupling reactions. Organic chemists often use it to create novel scaffoldings for bioactive molecules, aiming for better selectivity and stability. Beyond medicinal chemistry, the rigid scaffold and electron-withdrawing profile help tune optoelectronic properties in materials science. I worked alongside teams who leveraged these features to fine-tune the wavelengths of synthetic dyes, aiming for brighter signals in diagnostic platforms.
In educational and industrial labs, the small tweaks made possible by 8-Bromoquinazolin-(2,4)Dione often translate to real product breakthroughs. Teams using older, non-halogenated quinazolinones sometimes hit dead ends with stubborn reactivity; the bromo-derivative can be that difference-maker, enabling the attachment of bulky groups or fine-tuning molecular properties in ways that weren’t possible with simpler skeletons.
It’s easy to lump quinazolinones together, but subtle differences influence the path a project takes. The parent compound—quinazolin-(2,4)-dione—lacks functional sites for some of the more creative organic transformations. What makes 8-Bromoquinazolin-(2,4)Dione different is its readiness for modification at the bromine site. In hands-on terms, chemists find it more forgiving and less fussy when planning cross-coupling, as the bromine atom generally offers higher reactivity than its chloro or iodo counterparts. Yields in palladium-catalyzed reactions trend upwards, and the purification steps using this compound usually become less of a chore.
Looking at cost and accessibility, this molecule falls in line with other lab reagents—neither a luxury reserved for big-budget academic groups, nor a penny item. Suppliers who cater to both small research efforts and large-scale pharmaceutical syntheses keep it available in decent quantities, so labs don’t need to hoard supplies or redesign workflows around spot shortages. I’ve experienced firsthand how a single well-stocked reagent can save a project from delays, especially when deadlines pressure innovation at startup biotech firms or academic grant cycles.
Chemistry always brings a mix of excitement and responsibility, and this compound is no exception. Standard lab practices—gloves, eye protection, and fume hoods—keep researchers safe and the work environment healthy. Over the years, handling various bromo-substituted aromatics trained me to watch for dust and to consult safety sheets before scaling up processes. Making a habit of cataloging reaction results, keeping storage containers properly closed, and performing small-scaled pilot tests pays off in avoided mishaps. While no two labs operate identically, sharing these habits helps everyone stay alert and safe—especially with specialty chemicals where experience varies widely.
Lab life gets repetitive when the same reactions hit brick walls over and over. Introducing 8-Bromoquinazolin-(2,4)Dione into a workflow opens new branches. Chemists trying to advance anti-cancer drugs or novel antimicrobials often switch to this compound after simpler precursors get stuck or show dead ends in screenings. The ability to diversify at the 8-position means one core structure spawns whole libraries of candidate molecules. Over time, this speeds up discovery cycles and often improves the odds of finding a hit worth pursuing.
Material scientists who push the edge of displays and medical sensors also take advantage of the rigid backbone and the electronic effects of the bromine. Tailoring the performance of organic light-emitting diodes (OLEDs) or fine-tuning the absorption profiles for diagnostic imaging benefit from these tweaks. I’ve sat through enough project updates and academic conferences to know this compound’s reputation rises or falls on the results, not just the theoretical possibilities.
Any researcher or process manager recognizing familiar breakdowns—low yields, hard-to-purify intermediates, or finicky reactivity—finds themselves searching for alternatives. Picking 8-Bromoquinazolin-(2,4)Dione as a replacement often pays off, especially where traditional quinazolinones fall short. It’s a routine frustration to spend months chasing one set of reactions, only to see them derailed by side products or unsatisfying outcomes. Switching to a bromo-substituted scaffold can take away some of that pain.
Labs working to turn small discoveries into scalable solutions pay attention to reagents that show reliability batch to batch. Most teams cannot afford lost weeks repeating failed chemistry or running into equipment-clogging byproducts. Every hour saved is an hour earned for new thinking—this has played out year after year in both university and industry settings. Talking shop with other chemists, the consensus lands on molecules like this one: They expand the toolkit for both junior researchers and senior project leads.
Not every batch of specialty chemicals is created equal, and researchers want to see real data behind the label. Transparency around traceability, origin, and analytical support makes a noticeable difference. Reliable suppliers connect research teams to support documentation—from certificates of analysis to NMR and HPLC profiles. Talking with colleagues and reading lab notes, it’s easy to spot when reagent inconsistencies sneak in; dead ends and unexplained side reactions waste time and raw material. The peace of mind that comes from a chemical with a proven track record turns into faster progress and less time spent second-guessing the next step.
The marketplace for reagents now rewards companies that back their sales with both data and support. As a consumer and a researcher, I value more than just the molecule in the bottle; I’m paying for clear communication, reliable logistics, and access to answers. 8-Bromoquinazolin-(2,4)Dione tends to draw a loyal following from repeat users who know it won’t let them down at a crucial moment.
Green chemistry sits higher on the agenda these days, and for good reason. 8-Bromoquinazolin-(2,4)Dione’s practical advantages don’t always guarantee low environmental impact, but thoughtful users do find ways to reduce solvent waste and optimize reaction pathways. Solvent choices and downstream purification methods make a difference: Switching to aqueous workups, recycling chromatography solvents, and using smaller reaction scales during early research all help. During my own years in academic labs, even minor protocol tweaks—like replacing halogenated solvents—cut down on hazardous waste fees.
Institutions and companies placing sustainability at the center of their missions track hazards, emissions, and purchasing. Choosing stable, high-yield reagents contributes to fewer do-overs, and a well-behaved intermediate like this one often means fewer trips to the waste disposal team. Open communication within lab teams and between buyers and suppliers brings everyone a step closer to sustainable, circular chemistry practices. Over time, the industry’s appetite for practical, less wasteful options helps tilt innovation toward safer and greener outcomes.
New users often need time to get used to any unfamiliar compound’s quirks, and 8-Bromoquinazolin-(2,4)Dione is no exception. Early experiences in a project may involve debugging unexpected results or calibration surprises during analysis. I’ve found that careful literature searches, consultations with more experienced chemists, and attention to reliable protocols help keep things on track. Forums and published papers often map out successful approaches and share details about common pitfalls—whether it’s solubility limits, reaction scales, or purification tips.
Tools like NMR, mass spectrometry, and TLC help home in on the key differences from older routes. A thoughtful researcher spends just as much time checking the basics—glassware, stirring rates, temperature controls—as they do hunting for breakthrough discoveries. The patience to chase down small problems at the bench often pays exponential returns later, especially during scale-up.
Sharing outcomes, both good and bad, strengthens the research community. Open source databases, conference presentations, and journal publications all speed up the transfer of practical know-how. 8-Bromoquinazolin-(2,4)Dione’s popularity keeps rising as more scientists from diverse backgrounds pool their collective experience and report what works—and what doesn’t. These practices keep a feedback loop running, where success stories drive further exploration and failed routes warn others off less productive paths.
Companies pursuing patentable drug candidates, academic labs building partnerships, and industry/academia consortia looking for robust building blocks all stand to benefit from this ingredient’s flexibility. Each new application broadens what’s possible in both basic research and product development.
Trust forms the backbone of any scientific or industrial process. Experience counts—those who’ve run multiple projects understand the value of clear, reproducible procedures that deliver every time. Sticking to high standards for data, traceability, and ethical sourcing supports not just a single research goal, but the public’s trust in new medicines, materials, and technology.
Sharing honest insights—both from personal practice and verified reports—boosts community knowledge and avoids repeating well-worn mistakes. The best takeaways come from combining technical know-how with an open account of what actually works in real labs, for real people. Students, established researchers, and procurement teams all do better when they tap into the collective wisdom built over many cycles of trial, error, and ongoing improvements.
The best products in science don’t just solve problems—they become part of the language that researchers use to push boundaries. 8-Bromoquinazolin-(2,4)Dione earns a spot in many workflows not by promising to be a miracle solution, but by supporting progress day after day, run after run. Reliable supply, transparent documentation, and proven reactivity make it a staple for those who value both quality and new potential.
From early-stage exploration in the corners of academic research, to scale-up efforts inside pharma companies, this compound supports innovation by making well-known hurdles less daunting. Reliable tools shift the odds of discovery, opening doors for breakthroughs that might otherwise get stuck on the drawing board. A few well-chosen chemicals can change the pace—and the outcome—of a project, especially when supported by a network of other experienced users.
Having worked in both high-throughput screening teams and traditional synthesis groups, I’ve seen how much the right intermediate matters. Projects that seem stalled suddenly progress after a switch to a new scaffold or a better-tuned substrate. 8-Bromoquinazolin-(2,4)Dione sits squarely in that class of low-profile tools that quietly underpin forward movement in today’s most challenging research and development projects.